Computational studies of the binding mode and 3D-QSAR analyses of symmetric formimidoester disulfides: a new class of non-nucleoside HIV-1 reverse transcriptase inhibitor

被引:8
作者
Cichero, Elena [1 ]
Cesarini, Sara [1 ]
Spallarossa, Andrea [1 ]
Mosti, Luisa [1 ]
Fossa, Paola [1 ]
机构
[1] Univ Genoa, Dipartimento Sci Farmaceut, I-16132 Genoa, Italy
关键词
CoMFA; CoMSIA; 3D-QSAR; Disulfides; Docking; HIV-1; Non-nucleoside reverse transcriptase inhibitors; PARALLEL SYNTHESIS; NNRTIS; THERAPY; DESIGN;
D O I
10.1007/s00894-008-0402-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Symmetric formimidoester disulfides (DSs) have recently been identified as a new class of potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. Given that three geometric isomers for DSs are possible, a computational strategy based on molecular docking studies, followed by comparative molecular fields analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) was used in order to identify the most probable DS isomer interacting with RT, to elucidate the atomic details of the RT/DS interaction, and to identify key features impacting DS antiretroviral activity. The CoMFA model was found to be the more predictive, with values of r(ncv)(2) = 0.95, r(cv)(2) = 0.482, SEE=0.264, F=80, and r(pred)(2) = 0.73.
引用
收藏
页码:357 / 367
页数:11
相关论文
共 26 条
[1]   Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1 [J].
Balzarini, J .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (09) :921-944
[2]   Highly active antiretroviral therapy: Current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome [J].
Barbaro, G ;
Scozzafava, A ;
Mastrolorenzo, A ;
Supuran, CT .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (14) :1805-1843
[3]  
Brown AJL, 2003, J INFECT DIS, V187, P683, DOI 10.1086/367989
[4]   Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: Past, present, and future perspectives [J].
Campiani, G ;
Ramunno, A ;
Maga, G ;
Nacci, V ;
Fattorusso, C ;
Catalanotti, B ;
Morelli, E ;
Novellino, E .
CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (08) :615-657
[5]   Parallel one-pot synthesis and structure-activity relationship study of symmetric formimidoester disulfides as a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors [J].
Cesarini, Sara ;
Spallarossa, Andrea ;
Ranise, Angelo ;
Schenone, Silvia ;
Bruno, Olga ;
La Colla, Paolo ;
Casula, Laura ;
Collu, Gabriella ;
Sanna, Giuseppina ;
Loddo, Roberta .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (12) :6353-6363
[6]   Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors.: Part 1:: Parallel synthesis, molecular modelling and structure-activity relationship studies on O-[2-(hetero)arylethyl]-N-phenylthiocarbamates [J].
Cesarini, Sara ;
Spallarossa, Andrea ;
Ranise, Angelo ;
Fossa, Paola ;
La Colla, Paolo ;
Sanna, Giuseppina ;
Collu, Gabriella ;
Loddo, Roberta .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (07) :4160-4172
[7]   Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors.: Part 2:: Parallel synthesis, molecular modelling and structure-activity relationship studies on analogues of O-(2-phenylethyl)-N-phenylthiocarbamate [J].
Cesarini, Sara ;
Spallarossa, Andrea ;
Ranise, Angelo ;
Bruno, Olga ;
La Colla, Paolo ;
Secci, Barbara ;
Collu, Gabriella ;
Loddo, Roberta .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (07) :4173-4185
[8]  
CRAMER RD, 1989, PROG CLIN BIOL RES, V291, P1
[9]   New approaches toward anti-HIV chemotherapy [J].
De Clercq, E .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (05) :1297-1313
[10]   Non-nucleoside reverse transcriptase inhibitors (NNRTIs): Past, present, and future [J].
De Clercq, E .
CHEMISTRY & BIODIVERSITY, 2004, 1 (01) :44-64